Biogen Inc
NASDAQ: BIIB
$197.92
-$3.53 (-1.7%)
Real Time Data Delayed 15 Min.
BIIB Articles
Investors are not used to hearing is the word "biotech" used in the same sentence as anything to do with Warren Buffett and Berkshire Hathaway. Yet the portfolio managers have purchased shares of...
Published:
The January 31 data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Boeing, Etsy, Gilead Sciences, GoPro, Micron Technology, Newmont, Peloton Interactive, Pfizer, Valero Energy and...
Published:
Monday's top analyst upgrades, downgrades and initiations included Aimmune Therapeutics, Amgen, Biogen, Chevron, CRISPR, Exxon Mobil, Nike, Snap, Uber, Ulta Beauty and Verizon.
Published:
Thursday's top analyst upgrades, downgrades and initiations included Alphabet, Apple, AT&T, Biogen, CSX, Dow, Facebook, McDonald's, Microsoft and Tesla.
Published:
The January 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
If there is one group that can produce stock gains regardless of the daily market activities, that would be biotechnology and emerging pharmaceuticals. Coming up with a new approach or new way to...
Published:
These three health care companies included are expected to report their earnings on Tuesday morning.
Published:
Monday's top analyst upgrades, downgrades and initiations included Alphabet, Amazon.com, Apple, Biogen, Chewy, Comcast, Deere, Facebook, Intel, SolarEdge Technologies and Wynn Resorts.
Published:
24/7 Wall St. has put together a preview of the most prominent earnings reports this week, including Amazon.com, AT&T and General Electric.
Published:
The December 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks increased.
Published:
The December 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
The top analyst upgrades, downgrades and initiations for Friday included Adobe, Biogen, Bristol-Myers, Broadcom, Charles Schwab, Ciena, Etsy, Gilead, Oracle, Sarepta, Snap and Wayfair.
Published:
Last Updated:
The November 29 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Published:
Monday's top analyst upgrades, downgrades and initiations included ADT, Altria, Biogen, Charles Schwab, Chewy, Deere, Dollar Tree, eBay, Intel, Nike, Kroger, Peloton, Roku and Wells Fargo.
Published: